The US Bankruptcy Court granted an order for the joint administration of the Chapter 11 bankruptcy cases of Zymergen Inc. and its affiliates on October 3, 2023. The affiliates include Lodo Therapeutics Corporation, enEvolv, Inc., and Genesis Acquisition Sub, LLC. The cases would be jointly administered for administrative and procedural purposes.

Zymergen Inc. has been designated as the lead debtor.